Long-Term Efficacy, Survival, and Safety of Lu-177-DOTA(0), Tyr(3) octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors

Tessa Brabander; Wouter van der Zwan; Jaap Teunissen; BLR Kam; R.A. Feelders; W.W. de Herder; Casper van Eijck; Gaston Franssen; Eric Krenning; Dik Kwekkeboom

doi:10.1158/1078-0432.ccr-16-2743

Long-Term Efficacy, Survival, and Safety of Lu-177-DOTA(0), Tyr(3) octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors

Tessa Brabander, Wouter van der Zwan, Jaap Teunissen, BLR Kam, R.A. Feelders, W.W. de Herder, Casper van Eijck, Gaston Franssen, Eric Krenning, Dik Kwekkeboom

Research output: Contribution to journal › Article › Academic › peer-review

488 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	4617-4624
Number of pages	8
Journal	Clinical Cancer Research
Volume	23
Issue number	16
DOIs	https://doi.org/10.1158/1078-0432.ccr-16-2743
Publication status	Published - 2017

Research programs

EMC MM-01-40-01

Access to Document

10.1158/1078-0432.ccr-16-2743

http://hdl.handle.net/1765/101556

Cite this

Brabander, T., van der Zwan, W., Teunissen, J., Kam, BLR., Feelders, R. A., de Herder, W. W., van Eijck, C., Franssen, G., Krenning, E., & Kwekkeboom, D. (2017). Long-Term Efficacy, Survival, and Safety of Lu-177-DOTA(0), Tyr(3) octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors. Clinical Cancer Research, 23(16), 4617-4624. https://doi.org/10.1158/1078-0432.ccr-16-2743

@article{fc7e994055cf4bf5bf3b12c70852c5b3,

title = "Long-Term Efficacy, Survival, and Safety of Lu-177-DOTA(0), Tyr(3) octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors",

author = "Tessa Brabander and {van der Zwan}, Wouter and Jaap Teunissen and BLR Kam and R.A. Feelders and {de Herder}, W.W. and {van Eijck}, Casper and Gaston Franssen and Eric Krenning and Dik Kwekkeboom",

year = "2017",

doi = "10.1158/1078-0432.ccr-16-2743",

language = "Undefined/Unknown",

volume = "23",

pages = "4617--4624",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "16",

}

Brabander, T, van der Zwan, W, Teunissen, J, Kam, BLR, Feelders, RA , de Herder, WW , van Eijck, C , Franssen, G, Krenning, E & Kwekkeboom, D 2017, 'Long-Term Efficacy, Survival, and Safety of Lu-177-DOTA(0), Tyr(3) octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors', Clinical Cancer Research, vol. 23, no. 16, pp. 4617-4624. https://doi.org/10.1158/1078-0432.ccr-16-2743

TY - JOUR

T1 - Long-Term Efficacy, Survival, and Safety of Lu-177-DOTA(0), Tyr(3) octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors

AU - Brabander, Tessa

AU - van der Zwan, Wouter

AU - Teunissen, Jaap

AU - Kam, BLR

AU - Feelders, R.A.

AU - de Herder, W.W.

AU - van Eijck, Casper

AU - Franssen, Gaston

AU - Krenning, Eric

AU - Kwekkeboom, Dik

PY - 2017

Y1 - 2017

U2 - 10.1158/1078-0432.ccr-16-2743

DO - 10.1158/1078-0432.ccr-16-2743

M3 - Article

SN - 1078-0432

VL - 23

SP - 4617

EP - 4624

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 16

ER -